Case Study: Top 20 Biopharmaceutical Company achieves a successful product launch with OrangeFiery's market development strategy

Top 20 Biopharmaceutical Company drives 7 abstracts and posters with OrangeFiery

OrangeFiery partnered with a top 20 biopharmaceutical company that was preparing to launch a first-in-class therapy for hyperkalemia. The client's challenge was to better understand the opportunities for reaching and educating clinicians and at-risk patients about this condition, which had not seen a new treatment in 50 years, to support their product launch.

OrangeFiery's solution involved a comprehensive market development strategy. This included conducting a landscape assessment, building relationships with key advocacy groups, and creating unique partnerships to develop new educational resources and disease burden research. As a result, the product launch was successful. Measurable impacts included new, credible patient/HCP materials, a unique research partnership that yielded 7 abstracts and posters on hyperkalemia, and the quick establishment of the disease's burden to restart public dialogue.

Top 20 Biopharmaceutical Company